FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Norman Block

Research Profile

Disorders

Living Beings

Rats

Chemicals & Drugs

Anatomy

Physiology

Procedures

Co-author Network

Publications

TOP 3
Ferenc Rick; Norman Block; Andrew V Schally
Re: Editorial Comment on LHRH Antagonist Cetrorelix Reduces Prostate Size and Gene Expression of Proinflammatory Cytokines and Growth Factors in a Rat Model of Benign Prostatic Hyperplasia (Prostate 2011; 71: 736-747).
Miklos Jaszberenyi; Mehrdad Nadji; Andrew V Schally; Luca Szalontay; Irving Vidaurre; Norman Block; Ferenc Rick
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.
Ferenc Rick; Andrew Abi-Chaker; Norman Block; Gabor Halmos; Miklos Jaszberenyi; Arumugam R Jayakumar; AWTAR KRISHAN; Roberto Perez; Nagarajarao Shamaladevi; Luca Szalontay; Karoly Szepeshazi; Irving Vidaurre; Andrew V Schally
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Norman Block (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ferenc Rick; Norman Block; Andrew V Schally
Re: Editorial Comment on LHRH Antagonist Cetrorelix Reduces Prostate Size and Gene Expression of Proinflammatory Cytokines and Growth Factors in a Rat Model of Benign Prostatic Hyperplasia (Prostate 2011; 71: 736-747).
The Journal of urology 2013;189(4):1604-5.
2013: Miklos Jaszberenyi; Mehrdad Nadji; Andrew V Schally; Luca Szalontay; Irving Vidaurre; Norman Block; Ferenc Rick
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.
Oncotarget 2013;4(3):422-32.
2013: Ferenc Rick; Andrew Abi-Chaker; Norman Block; Gabor Halmos; Miklos Jaszberenyi; Arumugam R Jayakumar; AWTAR KRISHAN; Roberto Perez; Nagarajarao Shamaladevi; Luca Szalontay; Karoly Szepeshazi; Irving Vidaurre; Andrew V Schally
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(7):2617-22.
2012: Karoly Szepeshazi; Irving Vidaurre; Norman Block; Gabor Halmos; Ferenc Rick; Andrew V Schally; Luca Szalontay
Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.
Anti-cancer drugs 2012;23(9):906-13.
2012: Roberto Perez; Ricardo Rincon; Andrew V Schally; Irving Vidaurre; Norman Block; Ferenc Rick
Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers.
Oncotarget 2012;3(9):988-97.
2012: Nikolina Dioufa; Elena Farmaki; Hippokratis Kiaris; Christos Kittas; Athanasios G Papavassiliou; Andrew V Schally; Dimitris Vlahodimitropoulos; Norman Block; Ioulia Chatzistamou
Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas.
Hormones & cancer 2012;3(4):172-80.
2012: Karoly Szepeshazi; Irving Vidaurre; Andrew V Schally; Luca Szalontay; Daniel Benten; Norman Block; Gabor Halmos; Miklos Jaszberenyi; Gunhild Keller; Ferenc Rick
Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108].
Oncotarget 2012;3(7):686-99.
2012: Ferenc Rick; Andrew V Schally; Stephan Seitz; Andreas Stadlmayr; Luca Szalontay; Elmar Aigner; Norman Block; Stefan Buchholz; Christian Datz; AWTAR KRISHAN; Roberto Perez; Florian Hohla
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Cell cycle (Georgetown, Tex.) 2012;11(13):2518-25.
2012: Ferenc Rick; Andrew V Schally; Luca Szalontay; Karoly Szepeshazi; Irving Vidaurre; Marta Zarandi; Norman Block; Magdolna Kovacs; Mehrdad Nadji; Zoltan Rekasi
Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
The Journal of urology 2012;187(4):1498-504.
2012: Barbara Ludwig; Stefan Ludwig; Shiri Maimon; Tova Neufeld; Andreas Reichel; Avi Rotem; Tania Rozenshtein; Andrew V Schally; Janine Schmid; Noa Shabtay; Anja Steffen; Pnina Vardi; Gordon C Weir; Karina Yavriyants; Baruch Zimermann; Konstantin Bloch; Norman Block; Stefan R Bornstein; Mathias D Brendel; Triantafyllos Chavakis; Clark K Colton; Paul de Vos; Dimitri Azarov; Mariya Balyura; Uriel Barkai
Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(13):5022-7.
2012: Rudolf Lucas; Michael A Matthay; Aluya Oseghale; Ferenc Rick; Supriya Sridhar; Nagavedi S Umapathy; Alexander Dmitriyevich Verin; Richard E White; Guang Yang; Evgeny A Zemskov; Norman Block; Trinad Chakraborty; Boris A Gorshkov; Andrew V Schally
Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(6):2084-9.
2012: Anna Klukovits; Andrea Papadia; Andrew V Schally; Luca Szalontay; Jozsef Varga; Irving Vidaurre; Marta Zarandi; Norman Block; Gabor Halmos
Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
Cancer 2012;118(3):670-80.
2012: Ferenc Rick; Andrew V Schally; Luca Szalontay; Karoly Szepeshazi; Marta Zarandi; Norman Block; Stefan Buchholz; Florian Hohla; Mehrdad Nadji; Stephan Seitz
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(5):1655-60.
2012: Rosemeire M Kanashiro-Takeuchi; Claudia Rodrigues; Sarah M Selem; Andrew V Schally; Raul Dulce; Adriana V Treuer; Lauro M Takeuchi; Konstantinos E Hatzistergos; Ferenc Rick; Victoria Florea; Ellena C Paulino; Daniel R Gonzalez; Norman Block; Joshua M Hare
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI).
Proceedings of the National Academy of Sciences of the United States of America 2012;109(2):559-63.
2012: Luca Szalontay; Irving Vidaurre; Marta Zarandi; Ronald Benveniste; Norman Block; Mehrdad Nadji; Andrew V Schally; Magdolna Kovacs
Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.
Neuroendocrinology 2012;96(1):81-8.
2011: Janine Schmid; Charmaine J Simeonovic; Anja Steffen; Christian G Ziegler; Mathias D Brendel; Monika Ehrhart-Bornstein; Katia P Karalis; Yassemi Koutmani; Julio Licinio; Barbara Ludwig; Andrew V Schally; Norman Block; Stefan R Bornstein
Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(33):13722-7.
2011: Ferenc Rick; Andrew V Schally; Irving Vidaurre; Norman Block; Jesus B Fernandez; Gabor Halmos; Roberto Perez; Luca Szalontay
LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
The Prostate 2011;71(7):736-47.
2011: Bernadett Rozsa; Mehrdad Nadji; Andrew V Schally; Balazs Dezso; Tibor Flasko; Gyorgy Toth; Melinda Mile; Norman Block; Gabor Halmos
Receptors for luteinizing hormone-releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelix.
The Prostate 2011;71(5):445-52.
2011: Ferenc Rick; Andrew V Schally; Norman Block; Mehrdad Nadji; Karoly Szepeshazi; Marta Zarandi; Irving Vidaurre; Roberto Perez; Gabor Halmos; Luca Szalontay
Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(9):3755-60.
2011: Hippokratis Kiaris; Norman Block; Athanasios G Papavassiliou; Andrew V Schally
GHRH and wound healing.
Communicative & integrative biology 2011;4(1):82-3.
2011: Andrew V Schally; Jörg Engel; Gunter Emons; Norman Block; Jacek Pinski
Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors.
Current drug delivery 2011;8(1):11-25.
2010: Agnieszka Siejka; Andrew V Schally; Norman Block; Nektarios Barabutis
Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix.
BJU international 2010;106(9):1382-8.
2010: Nikolina Dioufa; Andrew V Schally; Ioulia Chatzistamou; Evi Moustou; Norman Block; Gary K Owens; Athanasios G Papavassiliou; Hippokratis Kiaris
Acceleration of wound healing by growth hormone-releasing hormone and its agonists.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(43):18611-5.
2010: Barbara Ludwig; Christian G Ziegler; Andrew V Schally; Claudius Richter; Anja Steffen; Normund Jabs; Richard H W Funk; Mathias D Brendel; Norman Block; Monika Ehrhart-Bornstein; Stefan R Bornstein
Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(28):12623-8.
2010: Agnieszka Siejka; Andrew V Schally; Norman Block; Nektarios Barabutis
Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells.
The Prostate 2010;70(10):1087-93.
2010: Rosemeire M Kanashiro-Takeuchi; Konstantinos Tziomalos; Lauro M Takeuchi; Adriana V Treuer; guillaume lamirault; Raul Dulce; Michael Hurtado; Yun Song; Norman Block; Ferenc Rick; Anna Klukovits; Qinghua Hu; Jozsef Varga; Andrew V Schally; Ivonne Schulman
Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(6):2604-9.
2010: Nektarios Barabutis; Agnieszka Siejka; Andrew V Schally; Norman Block; Renzhi Cai; Jozsef Varga
Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor.
Journal of molecular endocrinology 2010;44(2):127-34.
2009: Bernadett Rózsa; Aliz Juhász; Andrea Treszl; György Tóth; Tibor Flaskó; Balázs Dezsö; Norman Block; Andrew V Schally; Gabor Halmos
Expression of mRNA for human type-I LHRH receptor transcript forms in human benign prostatic hyperplasia.
International journal of oncology 2009;35(5):1053-9.
2009: George N Sfakianakis; Efrosyni Sfakianaki; Michalis Georgiou; Aldo N Serafini; Shabbir Ezuddin; Russ Kuker; Gastón Zilleruelo; Jose Strauss; Carolyn Abitbol; Jayanthi Chandar; Wacharee Seeherunvong; Jacque Bourgoignie; David Roth; Raymond J Leveillee; Vincent G Bird; Norman Block; Rafael Gosalbez; Andrew Labbie; Jorge Guerra; Jose Yrizarry
A renal protocol for all ages and all indications: mercapto-acetyl-triglycine (MAG3) with simultaneous injection of furosemide (MAG3-F0): a 17-year experience.
Seminars in nuclear medicine 2009;39(3):156-73.
2009: Wolfgang H Cerwinka; Norman Block
Civilian gunshot injuries of the penis: the Miami experience.
Urology 2009;73(4):877-80.
2009: Devendar Katkoori; Srinivas Samavedi; Merce Jorda; Norman Block; Murugesan Manoharan
A rare case of renal gastrinoma.
TheScientificWorldJournal 2009;9():501-4.
2009: Amar Deshpande; Norman Block; Jamie S Barkin
Taking a closer look at the rectal examination: beyond the basics.
The American journal of gastroenterology 2009;104(1):246-7; author reply 247.
2005: Vladimir Vincek; Mehdi Nassiri; Norman Block; Catherine Welsh; Mehrdad Nadji; Azorides R Morales
Methodology for preservation of high molecular-weight RNA in paraffin-embedded tissue: application for laser-capture microdissection.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2005;14(3):127-33.
2002: Merce Jorda; Azorides R Morales; Zeina Ghorab; Gustavo Fernandez; Mehrdad Nadji; Norman Block
Her2 expression in prostatic cancer: a comparison with mammary carcinoma.
The Journal of urology 2002;168(4 Pt 1):1412-4.
2002: Bal Lokeshwar; Marie G Selzer; Bao-Qian Zhu; Norman Block; Lorne M Golub
Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model.
International journal of cancer. Journal international du cancer 2002;98(2):297-309.
2001: Vinata B Lokeshwar; D Rubinowicz; G L Schroeder; E Forgacs; J D Minna; Norman Block; Mehrdad Nadji; Bal Lokeshwar
Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.
The Journal of biological chemistry 2001;276(15):11922-32.
2000: George N Sfakianakis; D J Cohen; R H Braunstein; Raymond J Leveillee; I Lerner; Vincent G Bird; E Sfakianakis; Michalis Georgiou; Norman Block; Charles M Lynne
MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolith.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(11):1813-22.
2000: Vinata B Lokeshwar; Norman Block
HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.
The Urologic clinics of North America 2000;27(1):53-61.
2000: Vinata B Lokeshwar; C Obek; HT Pham; D Wei; M J Young; Robert Duncan; Mark S Soloway; Norman Block
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
The Journal of urology 2000;163(1):348-56.
1999: David G McLeod; Paul F Schellhammer; Nicholas J Vogelzang; Mark S Soloway; Roohollah Sharifi; Norman Block; PM Venner; AL Patterson; Michael F Sarosdy; R P Kelley; GJ Kolvenbag
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group.
The Prostate 1999;40(4):218-24.
1999: Marie G Selzer; B Zhu; Norman Block; Bal Lokeshwar
CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer.
Annals of the New York Academy of Sciences 1999;878():678-82.
1999: B Zhu; Norman Block; Bal Lokeshwar
Interaction between stromal cells and tumor cells induces chemoresistance and matrix metalloproteinase secretion.
Annals of the New York Academy of Sciences 1999;878():642-6.
1999: Bal Lokeshwar; Gary G Schwartz; Marie G Selzer; Kerry L Burnstein; SH Zhuang; Norman Block; L Binderup
Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(3):241-8.
1998: Bal Lokeshwar; H L Houston-Clark; Marie G Selzer; Norman Block; L M Golub
Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.
Advances in dental research 1998;12(2):97-102.
1998: Raymond J Leveillee; Leonard Pinchuk; G J Wilson; Norman Block
A new self-expanding lined stent-graft in the dog ureter: radiological, gross, histopathological and scanning electron microscopic findings.
The Journal of urology 1998;160(5):1877-82.
1998: Vinata B Lokeshwar; Mark S Soloway; Norman Block
Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells.
Cancer letters 1998;131(1):21-7.
1998: Michael F Sarosdy; Paul F Schellhammer; Roohollah Sharifi; Norman Block; Mark S Soloway; PM Venner; AL Patterson; Nicholas J Vogelzang; Gerald Chodak; Eric A Klein; J J Schellenger; GJ Kolvenbag
Comparison of goserelin and leuprolide in combined androgen blockade therapy.
Urology 1998;52(1):82-8.
1997: Paul F Schellhammer; Roohollah Sharifi; Norman Block; Mark S Soloway; PM Venner; AL Patterson; Michael F Sarosdy; Nicholas J Vogelzang; J J Schellenger; GJ Kolvenbag
Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group.
Urology 1997;50(3):330-6.
1997: L H Klotz; Pramod C Sogani; Norman Block
Summary of intermittent endocrine therapy for advanced prostate cancer (by Laurence H. Klotz, MD, Harry W. Herr, MD, Michael J. Morse, MD, and Willet F. Whitmore, Jr, MD). 1986.
Seminars in urologic oncology 1997;15(2):117-22.
1997: HT Pham; Norman Block; Vinata B Lokeshwar
Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.
Cancer research 1997;57(4):778-83.
1997: Vinata B Lokeshwar; C Obek; Mark S Soloway; Norman Block
Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer.
Cancer research 1997;57(4):773-7.
1996: Paul F Schellhammer; Roohollah Sharifi; Norman Block; Mark S Soloway; PM Venner; AL Patterson; Michael F Sarosdy; Nicholas J Vogelzang; Y Chen; GJ Kolvenbag
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.
Cancer 1996;78(10):2164-9.
1996: S D Dudak; A Lopez; Norman Block; Bal Lokeshwar
Enhancement of radiation response of prostatic carcinoma by lonidamine.
Anticancer research 1996;16(6B):3665-71.
1996: H J Korman; R B Watson; Francisco Civantos; Norman Block; Mark S Soloway
Radical prostatectomy: is complete resection of the seminal vesicles really necessary?
The Journal of urology 1996;156(3):1081-3.
1996: J L Block; Norman Block; Bal Lokeshwar
Modulation of aromatase activity by growth factors in an androgen sensitive human prostate cancer cell line, LNCaP.
Cancer letters 1996;102(1-2):167-72.
1996: J L Block; Norman Block; Bal Lokeshwar
Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3,17-dione in an androgen sensitive human prostatic carcinoma cell line.
Cancer letters 1996;101(2):143-8.
1996: Vinata B Lokeshwar; Bal Lokeshwar; HT Pham; Norman Block
Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression.
Cancer research 1996;56(3):651-7.
1996: Paul F Schellhammer; Roohollah Sharifi; Norman Block; Mark S Soloway; PM Venner; AL Patterson; Michael F Sarosdy; Nicholas J Vogelzang; J Jones; GJ Kolvenbag
Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group.
Urology 1996;47(1A Suppl):54-60; discussion 80-4.
1995: Gerald Chodak; Roohollah Sharifi; B Kasimis; Norman Block; E Macramalla; G T Kennealey
Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma.
Urology 1995;46(6):849-55.
1995: Gaetano Ciancio; Sean M Ferrell; Norman Block
Flow-cytometric DNA analysis of paraffin-embedded renal cell carcinoma tissue from patients treated by parenchymal-sparing surgery.
British journal of urology 1995;76(5):570-4.
1995: Norman Block; Gaetano Ciancio
Conservative surgical treatment of renal cell carcinoma. The University of Miami experience.
The Journal of the Florida Medical Association 1995;82(9):607-11.
1995: D E Bejany; Norman Block
Modified ileocolonic neobladder in a woman with invasive transitional cell carcinoma of the bladder.
British journal of urology 1995;76(2):269.
1995: Nicholas J Vogelzang; Gerald Chodak; Mark S Soloway; Norman Block; P F Schellhammer; J A Smith; R J Caplan; G T Kennealey
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group.
Urology 1995;46(2):220-6.
1995: Bal Lokeshwar; Vinata B Lokeshwar; Norman Block
Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
Anticancer research 1995;15(4):1191-8.
1995: Paul F Schellhammer; Roohollah Sharifi; Norman Block; Mark S Soloway; PM Venner; AL Patterson; Michael F Sarosdy; Nicholas J Vogelzang; J Jones; GJ Kolvenbag
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group.
Urology 1995;45(5):745-52.
1995: A R Block; Norman Block
Leiomyoma of the epididymis.
The Journal of urology 1995;153(3 Pt 2):1063-5.
1995: Bal Lokeshwar; Sean M Ferrell; Norman Block
Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy.
Anticancer research 1995;15(1):93-8.
1994: Gaetano Ciancio; V A Politano; Sean M Ferrell; Norman Block
Renal parenchyma-sparing surgery as conservative treatment of renal cell carcinoma.
British journal of urology 1994;74(4):422-30.
1994: K S Hurkadli; Bal Lokeshwar; A R Sheth; Norman Block
Detection of prostatic-inhibin-like peptide in the cytoplasm of LNCaP cells, a human prostatic adenocarcinoma cell line.
The Prostate 1994;24(6):285-90.
1994: W E Bloch; Bal Lokeshwar; Sean M Ferrell; Norman Block
Enhancement of hyperthermic toxicity by lonidamine in the Dunning R3327G rat prostatic adenocarcinoma.
The Prostate 1994;24(3):131-8.
1994: P J Gkonos; C K Kwok; Norman Block; Bernard A Roos
Identification of the human seminal TRH-like peptide pGlu-Phe-Pro-NH2 in normal human prostate.
Peptides 1994;15(7):1281-3.
1993: Bal Lokeshwar; K S Hurkadli; A R Sheth; Norman Block
Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
Cancer research 1993;53(20):4855-9.
1993: Bal Lokeshwar; Marie G Selzer; Norman Block; Z Gunja-Smith
Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.
Cancer research 1993;53(19):4493-8.
1993: Gaetano Ciancio; Alan Pollack; Norman Block
Flow cytometric analysis of DNA and nuclear protein in paraffin-embedded tissue.
Cytometry 1993;14(2):205-9.
1993: C K Kwok; M D Horowitz; Alan Livingstone; Norman Block
Mature testicular teratoma with vena caval invasion presenting as pulmonary embolism.
The Journal of urology 1993;149(1):129-31.
1993: Gaetano Ciancio; Francisco Civantos; Norman Block
Malignant fibrous histiocytoma of spermatic cord.
Urology 1993;41(1):55-9.
1993: Alan Pollack; Gaetano Ciancio; Nicholas H A Terry; Norman Block
Recognition and reduction of artifacts from autolysis in paraffin-embedded tissue using DNA/nuclear protein flow cytometry.
Cytometry 1993;14(5):565-8.
1993: P J Gkonos; C K Kwok; Norman Block; Bernard A Roos
Expression of prostatic TRH-like peptides differs between species and between malignant and nonmalignant tissues.
The Prostate 1993;23(2):135-47.
1992: W E Bloch; Norman Block
Metastatic prostate cancer presenting as obstructive jaundice.
Urology 1992;40(5):456-7.
1992: Bal Lokeshwar; Norman Block
Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor beta.
Cancer research 1992;52(20):5821-5.
1992: Gaetano Ciancio; Norman Block
Small bowel perforation associated with intraperitoneal and extraperitoneal bladder perforation caused by stab wound to the penis.
The Journal of urology 1992;147(3):692-5.
1991: Mark S Soloway; Gerald Chodak; Nicholas J Vogelzang; Norman Block; P F Schellhammer; J A Smith; M Scott; G Kennealey; T C Gau
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group.
Urology 1991;37(1):46-51.
1988: George Irvin; M A Taupier; Norman Block; E Reiss
DNA patterns in parathyroid disease predict postoperative parathyroid hormone secretion.
Surgery 1988;104(6):1115-20.
1988: C F Gottlieb; G B Seibert; Norman Block
Interaction of irradiation and microwave-induced hyperthermia in the Dunning R3327G prostatic adenocarcinoma model.
Radiology 1988;169(1):243-7.
1988: Gaetano Ciancio; Alan Pollack; M A Taupier; Norman Block; George Irvin
Measurement of cell-cycle phase-specific cell death using Hoechst 33342 and propidium iodide: preservation by ethanol fixation.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1988;36(9):1147-52.
1988: Theodore I Malinin; F J Hornicek; Norman Block; G I Malinin
Aneuploidy of glandular epithelial cells in histologically normal prostate glands.
Experientia 1988;44(3):247-9.
1988: C F Gottlieb; G B Seibert; Norman Block
Systematic investigation into interaction of ionizing radiation and doxorubicin in the Dunning R3327G prostatic adenocarcinoma model.
NCI monographs : a publication of the National Cancer Institute 1988;(6):147-53.
1987: C F Gottlieb; Norman Block
A technique for localized tumor hyperthermia in small animals.
Medical instrumentation 1987;21(2):75-80.
1987: E C Eckstein; D Moran; E Gomez; M L Pomeranz; Norman Block; J Kline
A method for tethering dogs in a run.
Laboratory animal science 1987;37(2):234-5.
1986: L Ghandur-Mnaymneh; S Satterfield; Norman Block
Small cell carcinoma of the prostate gland with inappropriate antidiuretic hormone secretion: morphological, immunohistochemical and clinical expressions.
The Journal of urology 1986;135(6):1263-6.
1986: Alan Pollack; H Moulis; D L Prudhomme; Norman Block; George Irvin
Flow cytometric analysis of cell kinetic responses using measurements of correlated DNA and nuclear protein.
Annals of the New York Academy of Sciences 1986;468():55-66.
1985: Alan Pollack; H Moulis; D B Greenstein; Norman Block; George Irvin
Cell kinetic effects of incorporated 3H-thymidine on proliferating human lymphocytes: flow cytometric analysis using the DNA/nuclear protein method.
Cytometry 1985;6(5):428-36.
1985: D H Reese; H G Gratzner; Norman Block; V A Politano
Control of growth, morphology, and alkaline phosphatase activity by butyrate and related short-chain fatty acids in the retinoid-responsive 9-1C rat prostatic adenocarcinoma cell.
Cancer research 1985;45(5):2308-13.
1985: Alan Pollack; Norman Block; B J Stover; George Irvin
Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.
Cancer research 1985;45(3):1052-7.
1984: Alan Pollack; H Moulis; Norman Block; George Irvin
Quantitation of cell kinetic responses using simultaneous flow cytometric measurements of DNA and nuclear protein.
Cytometry 1984;5(5):473-81.
1984: B F Issell; G R Prout; Mark S Soloway; K B Cummings; G Brannen; R Veenema; M Flanagan; Norman Block; J L Summers; E A Levin
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa.
Cancer 1984;53(5):1025-8.
1984: Alan Pollack; Norman Block; B J Stover; M P Fuentes; George Irvin
Effects of the gonadotropin-releasing hormone agonist [D-leu6, desgly-NH2(10), proethylamide9]-GnRH (leuprolide) on R3327-G rat prostatic tumor growth.
The Journal of urology 1984;131(2):399-403.
1984: B Vorstman; Norman Block; V A Politano
The management of spermatic cord liposarcomas.
The Journal of urology 1984;131(1):66-9.
1983: D H Reese; B Gordon; H G Gratzner; A J Claflin; Theodore I Malinin; Norman Block; V A Politano
Effect of retinoic acid on the growth and morphology of a prostatic adenocarcinoma cell line cloned for the retinoid inducibility of alkaline phosphatase.
Cancer research 1983;43(11):5443-50.
1983: Alan Pollack; Norman Block; B J Stover; George Irvin; M P Fuentes; A J Claflin; Theodore I Malinin
In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy.
Journal of the National Cancer Institute 1983;70(5):907-14.
1982: B Rogers; Norman Block; Jeffrey B Raskin
Transcutaneous ileopyelostomy fiberoptic fulguration (TIFF). New treatment of renal pelvic tumors in solitary kidney.
Urology 1982;20(2):162-5.
1982: A J Claflin; Alan Pollack; Theodore I Malinin; Norman Block; George Irvin
Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
Journal of the National Cancer Institute 1982;69(1):79-87.
1982: Alan Pollack; D L Prudhomme; D B Greenstein; George Irvin; A J Claflin; Norman Block
Flow cytometric analysis of RNA content in different cell populations using pyronin Y and methyl green.
Cytometry 1982;3(1):28-35.
1982: Alan Pollack; George Irvin; Norman Block; R M Lipton; B J Stover; A J Claflin
Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.
Cancer research 1982;42(6):2184-90.
1981: F A Camuzzi; Norman Block; K Charyulu; S Thomsen; V A Politano
Leiomyosarcoma of prostate gland.
Urology 1981;18(3):295-7.
1981: J M Wasmer; Norman Block; V A Politano; F Tejada
Penile angiosarcoma presenting in bladder.
Urology 1981;18(2):179-80.
1981: J M Collins; C B Bagwell; Norman Block; A J Claflin; George Irvin; Alan Pollack; B Stover
Flow cytometric monitoring of R 3327 rat prostate carcinoma.
Investigative urology 1981;19(1):8-13.
1981: Alan Pollack; C B Bagwell; Norman Block; George Irvin; A J Claflin; B J Stover
Flow cytometric analysis of the response of the R3327-G rat prostatic adenocarcinoma to endocrine manipulation.
Journal of surgical oncology 1981;18(4):389-98.
1980: F S Shessel; Norman Block; B Stover; A Claflin; Theodore I Malinin; V A Politano
Endocrine manipulation of the Dunning prostatic adenocarcinoma.
Investigative urology 1980;17(6):529-33.
1980: F Camuzzi; Norman Block; B Stover; C Gottlieb; K Charyulu; V A Politano
Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adenocarcinoma (R-3327).
Urology 1980;15(5):443-7.
1980: M B Weitzenfeld; B T Brown; Gaston Morillo; Norman Block
Scrotal kidney and ureter: an unusual hernia.
The Journal of urology 1980;123(3):437-8.
1980: G D Mekras; Norman Block; H M Carrion; M Ishikoff
Urachal carcinoma: diagnosis by computerized axial tomography.
The Journal of urology 1980;123(2):275-7.
1980: Theodore I Malinin; A J Claflin; Norman Block; A L Brown
Establishment of primary cell cultures from normal and neoplastic human prostate gland tissue.
Progress in clinical and biological research 1980;37():161-80.
1979: K Charyulu; Norman Block; A Sudarsanam
Preoperative extended field radiation with I-125 seed implant in prostatic cancer: a preliminary report of a randomized study.
International journal of radiation oncology, biology, physics 1979;5(11-12):1957-61.
1979: C B Bagwell; Norman Block; George Irvin
Flow cytometric monitoring of prostatic carcinoma.
Surgical forum 1979;30():556-7.
1978: Norman Block; M M Sigel; Charles M Lynne; A B Ng; R A Grosberg
The initiation, progress, and diagnosis of dog bladder cancer induced by 4-aminobiphenyl.
Investigative urology 1978;16(1):50-4.
1978: J L Radomski; D Greenwald; W L Hearn; Norman Block; F M Woods
Nitrosamine formation in bladder infections and its role in the etiology of bladder cancer.
The Journal of urology 1978;120(1):48-50.
1978: A J Claflin; D L Vesely; J L Hudson; C B Bagwell; D C Lehotay; T M Lo; Mary Ann Fletcher; Norman Block; G S Levey
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata).
Proceedings of the National Academy of Sciences of the United States of America 1978;75(2):989-93.
1978: Norman Block; F Camuzzi; B Stover; A Claflin; M Troner; V A Politano
Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
Transactions of the American Association of Genito-Urinary Surgeons 1978;70():57-9.
1978: J Kline; E C Eckstein; Norman Block; F Lyon; R Kelly; D Morgan; S Ehrlich
Development of a total prosthetic urinary bladder.
Transactions - American Society for Artificial Internal Organs 1978;24():254-6.
1977: Norman Block; F Camuzzi; J Denefrio; M Troner; A Claflin; B Stover; V A Politano
Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.
Oncology 1977;34(3):110-3.
1977: Norman Block; E Stover; V A Politano
A prosthetic ureter in the dog.
Transactions - American Society for Artificial Internal Organs 1977;23():367-70.
1976: D Beraha; Norman Block; V A Politano
Simultaneous surgical management of bilateral hypernephroma: an alternative therapy.
The Journal of urology 1976;115(6):648-50.
1976: K K Charyulu; A Sudarsanam; Norman Block; P Houdek
Role of iodine-125 seeds in interstitial therapy.
Panminerva medica 1976;18(1-2):34-5.
1975: D F Rippe; G Ortiz-Muniz; Norman Block; Charles M Lynne; R B Shouger; M M Sigel
Urinary bladder carcinogenesis in the dog: preliminary studies on cellular immunity.
Transplantation proceedings 1975;7(4):495-501.
1974: L W Dowlen; Norman Block; V A Politano
Complications of transrectal biopsy examination of the prostate.
Southern medical journal 1974;67(12):1453-6.
1974: Norman Block
Chemotherapy of testicular cancer.
The Journal of the Florida Medical Association 1974;61(11):817-20.
1974: R Lankford; Norman Block; V A Politano
Gunshot wounds of the ureter: a review of 10 cases.
The Journal of trauma 1974;14(10):848-52.
1974: Norman Block; J Jaksy; A N Tessler
Carcinoma of urinary tract. Clinical significance of urinary phosphokinase activity in diagnosis.
Urology 1974;4(2):174-81.
1974: D Beraha; Norman Block; V A Politano
Myelolipoma of the kidney.
The Journal of urology 1974;112(1):19-21.
1974: J A Gordon; S Machiz; Norman Block; V A Politano
Salmonella typhosa infection of kidney.
Urology 1974;3(4):470-2.
1974: Norman Block; P Morales; E P Fazzini
Acutely traumatized canine ureter. Effects of low molecular weight dextran and surfactant pluronic F-68.
Urology 1974;3(2):190-4.
1973: Norman Block; P Rosen; W F Whitmore
Hemipelvectomy for advanced penile cancer.
The Journal of urology 1973;110(6):703-7.
1973: Norman Block; W F Whitmore
Leukemoid reaction, thrombocytosis and hypercalcemia associated with bladder cancer.
The Journal of urology 1973;110(6):660-3.
1973: Norman Block; H G Grabstald; M R Melamed
Congenital mesoblastic nephroma (leiomyomatous hamartoma): first adult case.
The Journal of urology 1973;110(4):380-3.
1973: M Golimbu; Norman Block; P A Morales
Ureterovesical flap operation for middle and upper ureteral repair.
Investigative urology 1973;10(4):313-7.
1972: Norman Block; D Weber; R Schinella
Blue nevi and other melanotic lesions of the prostate: report of 3 cases and review of the literature.
The Journal of urology 1972;107(1):85-7.
1971: Norman Block; A N Tessler
Transsexualism and surgical procedures.
Surgery, gynecology & obstetrics 1971;132(3):517-25.
1971: Norman Block; R S Hotchkiss
Malignant melanoma of the female urethra: report of a case with 5-year survival and review of the literature.
The Journal of urology 1971;105(2):251-5.